‹ Back
Ipamorelin
The story
Ipamorelin came out of Novo Nordisk in Copenhagen. In 1998 Kirsten Raun and colleagues named it the first selective growth hormone secretagogue: in pigs it released growth hormone as strongly as GHRP-6 but left ACTH and cortisol flat, even at 200 times the dose. Danish work then showed in human volunteers that each dose gives a single growth hormone peak at about 40 minutes and clears in about two hours. Further Danish work showed it grew bone length in young rats and protected bone formation from steroid damage. The ghrelin receptor itself was cloned in 1996, and its natural key, ghrelin, was found in 1999 by Masayasu Kojima and Kenji Kangawa in Japan.
Sources
Read the original sources
- Ipamorelin, the first selective growth hormone secretagogue. (1998 · Abstract; full methods not assumed · checked 2026-10-13)
- Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers (Abstract · checked 2026-10-13)
- Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats (Abstract · checked 2026-10-13)
- The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats (Abstract · checked 2026-10-13)
- A receptor in pituitary and hypothalamus that functions in growth hormone release (Abstract · checked 2026-10-13)
- Ghrelin is a growth-hormone-releasing acylated peptide from stomach (Abstract · checked 2026-10-13)